Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers

Cellular and Molecular Life Sciences

Volumn 72, Issue 9, 2015, Pages 1825-1837

  Hsieh, Meng Hsun ^a   Tsai, Cheng Hui ^a   Lin, Chuan Chuan ^b   Li, Tsai Kun ^a   Hung, Ting Wei ^a   Chang, Li Te ^a   Hsin, Ling Wei ^a,c   Teng, Shu Chun ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Alternative lengthening of telomeres; ICRF 193; Recombination; Telomere

Indexed keywords

4,4'-(1,2-DIMETHYL-1,2-ETHANEDIYL)BIS-2,6-PIPERAZINEDIONE; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; PIPERAZINE DERIVATIVE; TELOMERASE; TELOMERE BINDING PROTEIN;

ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; GENE DELETION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASMS; PATHOLOGY; TELOMERE HOMEOSTASIS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; NEOPLASMS; PIPERAZINES; TELOMERASE; TELOMERE HOMEOSTASIS; TELOMERE-BINDING PROTEINS; TOPOISOMERASE II INHIBITORS;

EID: 84931458596     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1783-0     Document Type: Article

References (61)

1. Wellinger RJ, Zakian VA (2012) Everything you ever wanted to know about Saccharomyces cerevisiae telomeres: beginning to end. Genetics 191:1073-1105
2. de Lange T (2002) Protection of mammalian telomeres. Oncogene 21:532-540
3. Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413
4. Vega LR, Mateyak MK, Zakian VA (2003) Getting to the end: telomerase access in yeast and humans. Nat Rev Mol Cell Biol 4:948-959
5. Artandi SE, DePinho RA (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 10:39-46
6. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271-1274
7. Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26:447-450
8. Reddel RR, Bryan TM, Colgin LM, Perrem KT, Yeager TR (2001) Alternative lengthening of telomeres in human cells. Radiat Res 155:194-200
9. Singer MS, Gottschling DE (1994) TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266:404-409
10. Teng SC, Zakian VA (1999) Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol Cell Biol 19:8083-8093
11. Chen Q, Ijpma A, Greider CW (2001) Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol Cell Biol 21:1819-1827
12. Huang P, Pryde FE, Lester D et al (2001) SGS1 is required for telomere elongation in the absence of telomerase. Curr Biol 11:125-129
13. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, Guarente L (2001) The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J 20:905-913
14. Teng SC, Chang J, McCowan B, Zakian VA (2000) Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell 6:947-952
15. Tsai HJ, Huang WH, Li TK et al (2006) Involvement of topoisomerase III in telomere-telomere recombination. J Biol Chem 281:13717-13723
16. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175-4179
17. Marcand S, Gilson E, Shore D (1997) A protein-counting mechanism for telomere length regulation in yeast. Science 275:986-990
18. Li TK, Liu LF (2001) Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol 41:53-77
19. Snapka RM, Woo SH, Blokhin AV, Witiak DT (1996) Inhibition of topoisomerase II by ICRF-193, the meso isomer of 2,3-bis(2,6-dioxopiperazin-4-yl)butane. Critical dependence on 2,3-butanediyl linker absolute configuration. Biochem Pharmacol 52:543-549
20. Wasserman RA, Austin CA, Fisher LM, Wang JC (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast. Cancer Res 53:3591-3596
21. Wasserman RA, Wang JC (1994) Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine. Cancer Res 54:1795-1800
22. Koshland D, Hartwell LH (1987) The structure of sister minichromosome DNA before anaphase in Saccharomyces cerevisiae. Science 238:1713-1716
23. Holm C, Stearns T, Botstein D (1989) DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol Cell Biol 9:159-168
24. Lundblad V, Szostak JW (1989) A mutant with a defect in telomere elongation leads to senescence in yeast. Cell 57:633-643
25. Smogorzewska A, de Lange T (2004) Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177-208
26. Anbalagan S, Bonetti D, Lucchini G, Longhese MP (2011) Rif1 supports the function of the CST complex in yeast telomere capping. PLoS Genet, e1002024
27. Marcand S, Pardo B, Gratias A, Cahun S, Callebaut I (2008) Multiple pathways inhibit NHEJ at telomeres. Genes Dev 22:1153-1158
28. Luo K, Vega-Palas MA, Grunstein M (2002) Rap1-Sir4 binding independent of other Sir, yKu, or histone interactions initiates the assembly of telomeric heterochromatin in yeast. Genes Dev 16:1528-1539
29. Mirabella A, Gartenberg MR (1997) Yeast telomeric sequences function as chromosomal anchorage points in vivo. EMBO J 16:523-533
30. Park S, Patterson EE, Cobb J, Audhya A, Gartenberg MR, Fox CA (2011) Palmitoylation controls the dynamics of budding-yeast heterochromatin via the telomere-binding protein Rif1. Proc Natl Acad Sci USA 108:14572-14577
31. Wilson-Sali T, Hsieh TS (2002) Generation of double-stranded breaks in hypernegatively supercoiled DNA by Drosophila topoisomerase IIIbeta, a type IA enzyme. J Biol Chem 277:26865-26871
32. Hardy CF, Sussel L, Shore D (1992) A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation. Genes Dev 6:801-814
33. Wotton D, Shore D (1997) A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae. Genes Dev 11:748-760
34. Corbett KD, Berger JM (2004) Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu Rev Biophys Biomol Struct 33:95-118
35. Worland ST, Wang JC (1989) Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J Biol Chem 264:4412-4416
36. Grobelny JV, Godwin AK, Broccoli D (2000) ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J Cell Sci 113(Pt 24):4577-4585
37. Takai H, Smogorzewska A, de Lange T (2003) DNA damage foci at dysfunctional telomeres. Curr Biol 13:1549-1556
38. Saharia A, Stewart SA (2009) FEN1 contributes to telomere stability in ALT-positive tumor cells. Oncogene 28:1162-1167
39. Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 9:338-350
40. Roca J, Ishida R, Berger JM, Andoh T, Wang JC (1994) Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci USA 91:1781-1785
41. Creighton AM, Hellmann K, Whitecross S (1969) Antitumour activity in a series of bisdiketopiperazines. Nature 222:384-385
42. Hellmann K, Newton KA, Whitmore DN, Hanham IW, Bond JV (1969) Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma. Br Med J 1:822-824
43. Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11:319-330
44. Nabetani A, Ishikawa F (2011) Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. J Biochem 149:5-14
45. Wang RC, Smogorzewska A, de Lange T (2004) Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119:355-368
46. Dejardin J, Kingston RE (2009) Purification of proteins associated with specific genomic Loci. Cell 136:175-186
47. Lovejoy CA, Li W, Reisenweber S et al (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8:e1002772
48. Ira G, Malkova A, Liberi G, Foiani M, Haber JE (2003) Srs2 and Sgs1-Top3 suppress crossovers during double-strand break repair in yeast. Cell 115:401-411
49. Plank JL, Wu J, Hsieh TS (2006) Topoisomerase IIIalpha and Bloom's helicase can resolve a mobile double Holliday junction substrate through convergent branch migration. Proc Natl Acad Sci USA 103:11118-11123
50. Ye J, Lenain C, Bauwens S et al (2010) TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell 142:230-242
51. Signon L, Malkova A, Naylor ML, Klein H, Haber JE (2001) Genetic requirements for RAD51- and RAD54-independent break-induced replication repair of a chromosomal double-strand break. Mol Cell Biol 21:2048-2056
52. Gotta M, Laroche T, Formenton A, Maillet L, Scherthan H, Gasser SM (1996) The clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in wild-type Saccharomyces cerevisiae. J Cell Biol 134:1349-1363
53. Bhattacharyya S, Keirsey J, Russell B et al (2009) Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates. J Biol Chem 284:14966-14977
54. Stavropoulos DJ, Bradshaw PS, Li X et al (2002) The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 11:3135-3144
55. Nikolaou C, Bermudez I, Manichanh C et al (2013) Topoisomerase II regulates yeast genes with singular chromatin architectures. Nucleic Acids Res 41:9243-9256
56. Buseman CM, Wright WE, Shay JW (2012) Is telomerase a viable target in cancer? Mutat Res 730:90-97
57. Henson JD, Neumann AA, Yeager TR, Reddel RR (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610
58. Bechter OE, Zou Y, Walker W, Wright WE, Shay JW (2004) Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition. Cancer Res 64:3444-3451
59. Hu J, Hwang SS, Liesa M et al (2012) Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148:651-663
60. Shay JW, Reddel RR, Wright WE (2012) Cancer. Cancer and telomeres - an ALTernative to telomerase. Science 336:1388-1390
61. Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635-692